The authors reviewed clinical and financial data for all patients trea
ted for nontraumatic subarachnoid hemorrhage (SAH) and unruptured cere
bral aneurysms at their institution between June 1993 and December 199
4. This study sought to identify specific areas of high resource utili
zation that may be amenable to reduction of expenditures without compr
omising quality of care. Detailed hospital financial data were correla
ted with clinical grade and course. Areas of high resource use were id
entified based on patient charges and category-specific loaded hospita
l cost. Patients were divided into four groups: Group 1. surgically tr
eated unruptured aneurysms (28 patients); Group 2, acute SAH (42 patie
nts); Group 3, SAH with vasospasm (32 patients); and Group 4, SAH with
negative angiogram (10 patients). Total cost per patient (mean +/- st
andard deviation in thousands of U.S. dollars) was highest for Group 3
(38.4 +/- 21.31 vs. Group 1, 12.7 +/- 8.8; Group 2, 22.6 +/- 20.9; an
d Group 4 25.0 +/- 33.5) and correlated with hospital length of stay,
Hunt and Hess grade, and Fisher grade. Areas of highest hospital cost
were not always reflected in patient charges. The three areas of highe
st cost accounted for 48.5% of the total cost and were: 1) intensive c
are unit ICU) room (Group 1, 2.5 +/- 3.5; Group 2, 7.0 +/- 9.2; Group
3, 11.0 +/- 7.8; and Group 4, 7.9 +/- 14.1); 2) arteriography (Group 1
, 1.7 +/- 1.2; Group 2, 2.1 +/- 1.5; Group 3, 4.1 +/- 2.1; and Group 4
, 2.2 +/- 0.7); and 3) ICU medicosurgical supplies (Group 1, 1.7 +/- 0
.8; Group 2, 2.0 +/- 1.5; Group 3, 3.7 +/- 1.7; and Group 4, 2.0 +/- 3
.0). It is concluded that cost containment strategies should be based
on cost rather than charge and novel approaches will be required to re
duce the cost of treating patients with SAH. Such approaches might inc
lude preventing vasospasm, reducing ICU stay, selective use of arterio
graphy, and reducing the cost of supplies.